Global Radiopharmaceutical Solutions Market Growth (Status and Outlook) 2026-2032
The global Radiopharmaceutical Solutions market size is predicted to grow from US$ 8033 million in 2025 to US$ 14113 million in 2032; it is expected to grow at a CAGR of 8.5% from 2026 to 2032.
Radiopharmaceutical Solutions refer to a comprehensive system encompassing the research, development, production, preparation, distribution, and clinical application of radiopharmaceuticals. This involves combining radioisotopes with specific biomolecules (such as ligands, antibodies, or small molecules) for diagnostic imaging (PET/SPECT) or targeted therapy (RLT/TRT) of diseases.
Gross Margin Level
The gross margin of the radiopharmaceutical solutions industry is typically significantly higher than that of generic drugs, general medical consumables, and most generic formulations. This is because it's not an industry that simply profits from raw material markups; rather, it's a high-barrier-to-entry sector where value is determined by a combination of factors, including radionuclide acquisition, radiolabeling, GMP hot chamber manufacturing, timely delivery, cold chain and radiation safety management, hospital access, and clinical support. Publicly available company data supports this: Lantheus's revenue in Q1 2025 was $373 million, with a gross profit of $238 million, corresponding to a gross margin of approximately 63.8%; Telix disclosed an overall gross margin of 53% for the first half of 2025, while the core Illuccix product maintained a gross margin of 64%. Based on the publicly available performance of these leading companies, the industry's gross profit margin can be roughly understood as follows: Mature diagnostic radiopharmaceuticals and branded PET/SPECT products typically have a margin between 50% and 65%. Companies with strong distribution networks but handling more compounding and third-party sales will have slightly lower margins. Companies producing therapeutic radiopharmaceuticals, therapeutic products, high-barrier platforms for alpha/beta radionuclides, and those with capabilities in rare isotopes can theoretically maintain higher margins, but they also face greater pressure from capacity investment, quality control, and compliance costs.
Industry Drivers
The growth of this industry primarily stems from the continued rise in the global cancer burden. The WHO indicates that there were approximately 20 million new cancer cases globally in 2022, and this number is projected to exceed 35 million by 2050, a 77% increase from 2022. This directly drives the expansion of demand for tumor imaging diagnostics, precision stratification, and targeted radiotherapy. The second core driver is the accelerated commercialization of therapeutic radiopharmaceuticals, with specific data indicating that growth stems from rising cancer and cardiovascular disease prevalence, as well as increased demand for diagnostic and therapeutic radiopharmaceuticals and medical isotopes. The third driver is that therapeutic radiopharmaceuticals are growing faster than diagnostic radiopharmaceuticals; in the same report, the projected growth rate for the therapeutic nuclear medicine sub-segment is higher than that for the diagnostic sub-segment, indicating that the industry is rapidly upgrading from 'image-assisted' to 'precision treatment platform.' Furthermore, the widespread adoption of hybrid imaging technologies such as PET/CT and SPECT/CT, the construction of nuclear medicine departments in hospitals, the expansion of isotope production capacity, and the introduction of new radionuclide platforms are all continuously boosting the industry's prosperity.
LPI (LP Information)' newest research report, the ?Radiopharmaceutical Solutions Industry Forecast? looks at past sales and reviews total world Radiopharmaceutical Solutions sales in 2025, providing a comprehensive analysis by region and market sector of projected Radiopharmaceutical Solutions sales for 2026 through 2032. With Radiopharmaceutical Solutions sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radiopharmaceutical Solutions industry.
This Insight Report provides a comprehensive analysis of the global Radiopharmaceutical Solutions landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Radiopharmaceutical Solutions portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Radiopharmaceutical Solutions market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radiopharmaceutical Solutions and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radiopharmaceutical Solutions.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceutical Solutions market by product type, application, key players and key regions and countries.
Segmentation by Type:
Radiopharmaceutical Solutions refer to a comprehensive system encompassing the research, development, production, preparation, distribution, and clinical application of radiopharmaceuticals. This involves combining radioisotopes with specific biomolecules (such as ligands, antibodies, or small molecules) for diagnostic imaging (PET/SPECT) or targeted therapy (RLT/TRT) of diseases.
Gross Margin Level
The gross margin of the radiopharmaceutical solutions industry is typically significantly higher than that of generic drugs, general medical consumables, and most generic formulations. This is because it's not an industry that simply profits from raw material markups; rather, it's a high-barrier-to-entry sector where value is determined by a combination of factors, including radionuclide acquisition, radiolabeling, GMP hot chamber manufacturing, timely delivery, cold chain and radiation safety management, hospital access, and clinical support. Publicly available company data supports this: Lantheus's revenue in Q1 2025 was $373 million, with a gross profit of $238 million, corresponding to a gross margin of approximately 63.8%; Telix disclosed an overall gross margin of 53% for the first half of 2025, while the core Illuccix product maintained a gross margin of 64%. Based on the publicly available performance of these leading companies, the industry's gross profit margin can be roughly understood as follows: Mature diagnostic radiopharmaceuticals and branded PET/SPECT products typically have a margin between 50% and 65%. Companies with strong distribution networks but handling more compounding and third-party sales will have slightly lower margins. Companies producing therapeutic radiopharmaceuticals, therapeutic products, high-barrier platforms for alpha/beta radionuclides, and those with capabilities in rare isotopes can theoretically maintain higher margins, but they also face greater pressure from capacity investment, quality control, and compliance costs.
Industry Drivers
The growth of this industry primarily stems from the continued rise in the global cancer burden. The WHO indicates that there were approximately 20 million new cancer cases globally in 2022, and this number is projected to exceed 35 million by 2050, a 77% increase from 2022. This directly drives the expansion of demand for tumor imaging diagnostics, precision stratification, and targeted radiotherapy. The second core driver is the accelerated commercialization of therapeutic radiopharmaceuticals, with specific data indicating that growth stems from rising cancer and cardiovascular disease prevalence, as well as increased demand for diagnostic and therapeutic radiopharmaceuticals and medical isotopes. The third driver is that therapeutic radiopharmaceuticals are growing faster than diagnostic radiopharmaceuticals; in the same report, the projected growth rate for the therapeutic nuclear medicine sub-segment is higher than that for the diagnostic sub-segment, indicating that the industry is rapidly upgrading from 'image-assisted' to 'precision treatment platform.' Furthermore, the widespread adoption of hybrid imaging technologies such as PET/CT and SPECT/CT, the construction of nuclear medicine departments in hospitals, the expansion of isotope production capacity, and the introduction of new radionuclide platforms are all continuously boosting the industry's prosperity.
LPI (LP Information)' newest research report, the ?Radiopharmaceutical Solutions Industry Forecast? looks at past sales and reviews total world Radiopharmaceutical Solutions sales in 2025, providing a comprehensive analysis by region and market sector of projected Radiopharmaceutical Solutions sales for 2026 through 2032. With Radiopharmaceutical Solutions sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Radiopharmaceutical Solutions industry.
This Insight Report provides a comprehensive analysis of the global Radiopharmaceutical Solutions landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Radiopharmaceutical Solutions portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Radiopharmaceutical Solutions market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Radiopharmaceutical Solutions and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Radiopharmaceutical Solutions.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceutical Solutions market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Diagnostic Radiopharmaceuticals
- Therapeutic Radiopharmaceuticals
- Others
- Radiopharmaceuticals that Emit Single Photons
- Radiopharmaceuticals that Emit Positrons
- Radiopharmaceuticals that Emit Beta Particles
- Radiopharmaceuticals that Emit Alpha Particles
- Injectable Solutions
- Oral Solutions
- Granules
- Others
- Hospital
- Specialist Clinic
- Biopharmaceutical Company
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Curium
- Siemens
- GE HealthCare
- Lantheus
- Jubilant Radiopharma
- Cardinal Health
- Telix Pharmaceuticals
- ITM Isotope Technologies Munich
- Bracco Imaging
- Bayer
- Eli Lilly
- Jubilant Pharma
- Aurobindo Pharma
- Sinotau
- Global Medical Solutions
- SOFIE Biosciences
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radiopharmaceutical Solutions Market Size (2021-2032)
2.1.2 Radiopharmaceutical Solutions Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Radiopharmaceutical Solutions by Country/Region (2021, 2025 & 2032)
2.2 Radiopharmaceutical Solutions Segment by Type
2.2.1 Diagnostic Radiopharmaceuticals
2.2.2 Therapeutic Radiopharmaceuticals
2.2.3 Others
2.2.4 Radiopharmaceutical Solutions Market Size by Type
2.2.4.1 Radiopharmaceutical Solutions Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Radiopharmaceutical Solutions Market Size Market Share by Type (2021-2026)
2.3 Radiopharmaceutical Solutions Segment by Types of Radioactive Nuclides
2.3.1 Radiopharmaceuticals that Emit Single Photons
2.3.2 Radiopharmaceuticals that Emit Positrons
2.3.3 Radiopharmaceuticals that Emit Beta Particles
2.3.4 Radiopharmaceuticals that Emit Alpha Particles
2.3.5 Radiopharmaceutical Solutions Market Size by Types of Radioactive Nuclides
2.3.5.1 Radiopharmaceutical Solutions Market Size CAGR by Types of Radioactive Nuclides (2021 VS 2025 VS 2032)
2.3.5.2 Global Radiopharmaceutical Solutions Market Size Market Share by Types of Radioactive Nuclides (2021-2026)
2.4 Radiopharmaceutical Solutions Segment by Dosage Forms
2.4.1 Injectable Solutions
2.4.2 Oral Solutions
2.4.3 Granules
2.4.4 Others
2.4.5 Radiopharmaceutical Solutions Market Size by Dosage Forms
2.4.5.1 Radiopharmaceutical Solutions Market Size CAGR by Dosage Forms (2021 VS 2025 VS 2032)
2.4.5.2 Global Radiopharmaceutical Solutions Market Size Market Share by Dosage Forms (2021-2026)
2.5 Radiopharmaceutical Solutions Segment by Application
2.5.1 Hospital
2.5.2 Specialist Clinic
2.5.3 Biopharmaceutical Company
2.5.4 Others
2.5.5 Radiopharmaceutical Solutions Market Size by Application
2.5.5.1 Radiopharmaceutical Solutions Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global Radiopharmaceutical Solutions Market Size Market Share by Application (2021-2026)
3 RADIOPHARMACEUTICAL SOLUTIONS MARKET SIZE BY PLAYER
3.1 Radiopharmaceutical Solutions Market Size Market Share by Player
3.1.1 Global Radiopharmaceutical Solutions Revenue by Player (2021-2026)
3.1.2 Global Radiopharmaceutical Solutions Revenue Market Share by Player (2021-2026)
3.2 Global Radiopharmaceutical Solutions Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RADIOPHARMACEUTICAL SOLUTIONS BY REGION
4.1 Radiopharmaceutical Solutions Market Size by Region (2021-2026)
4.2 Global Radiopharmaceutical Solutions Annual Revenue by Country/Region (2021-2026)
4.3 Americas Radiopharmaceutical Solutions Market Size Growth (2021-2026)
4.4 APAC Radiopharmaceutical Solutions Market Size Growth (2021-2026)
4.5 Europe Radiopharmaceutical Solutions Market Size Growth (2021-2026)
4.6 Middle East & Africa Radiopharmaceutical Solutions Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Radiopharmaceutical Solutions Market Size by Country (2021-2026)
5.2 Americas Radiopharmaceutical Solutions Market Size by Type (2021-2026)
5.3 Americas Radiopharmaceutical Solutions Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radiopharmaceutical Solutions Market Size by Region (2021-2026)
6.2 APAC Radiopharmaceutical Solutions Market Size by Type (2021-2026)
6.3 APAC Radiopharmaceutical Solutions Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Radiopharmaceutical Solutions Market Size by Country (2021-2026)
7.2 Europe Radiopharmaceutical Solutions Market Size by Type (2021-2026)
7.3 Europe Radiopharmaceutical Solutions Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radiopharmaceutical Solutions by Region (2021-2026)
8.2 Middle East & Africa Radiopharmaceutical Solutions Market Size by Type (2021-2026)
8.3 Middle East & Africa Radiopharmaceutical Solutions Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RADIOPHARMACEUTICAL SOLUTIONS MARKET FORECAST
10.1 Global Radiopharmaceutical Solutions Forecast by Region (2027-2032)
10.1.1 Global Radiopharmaceutical Solutions Forecast by Region (2027-2032)
10.1.2 Americas Radiopharmaceutical Solutions Forecast
10.1.3 APAC Radiopharmaceutical Solutions Forecast
10.1.4 Europe Radiopharmaceutical Solutions Forecast
10.1.5 Middle East & Africa Radiopharmaceutical Solutions Forecast
10.2 Americas Radiopharmaceutical Solutions Forecast by Country (2027-2032)
10.2.1 United States Market Radiopharmaceutical Solutions Forecast
10.2.2 Canada Market Radiopharmaceutical Solutions Forecast
10.2.3 Mexico Market Radiopharmaceutical Solutions Forecast
10.2.4 Brazil Market Radiopharmaceutical Solutions Forecast
10.3 APAC Radiopharmaceutical Solutions Forecast by Region (2027-2032)
10.3.1 China Radiopharmaceutical Solutions Market Forecast
10.3.2 Japan Market Radiopharmaceutical Solutions Forecast
10.3.3 Korea Market Radiopharmaceutical Solutions Forecast
10.3.4 Southeast Asia Market Radiopharmaceutical Solutions Forecast
10.3.5 India Market Radiopharmaceutical Solutions Forecast
10.3.6 Australia Market Radiopharmaceutical Solutions Forecast
10.4 Europe Radiopharmaceutical Solutions Forecast by Country (2027-2032)
10.4.1 Germany Market Radiopharmaceutical Solutions Forecast
10.4.2 France Market Radiopharmaceutical Solutions Forecast
10.4.3 UK Market Radiopharmaceutical Solutions Forecast
10.4.4 Italy Market Radiopharmaceutical Solutions Forecast
10.4.5 Russia Market Radiopharmaceutical Solutions Forecast
10.5 Middle East & Africa Radiopharmaceutical Solutions Forecast by Region (2027-2032)
10.5.1 Egypt Market Radiopharmaceutical Solutions Forecast
10.5.2 South Africa Market Radiopharmaceutical Solutions Forecast
10.5.3 Israel Market Radiopharmaceutical Solutions Forecast
10.5.4 Turkey Market Radiopharmaceutical Solutions Forecast
10.6 Global Radiopharmaceutical Solutions Forecast by Type (2027-2032)
10.7 Global Radiopharmaceutical Solutions Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Radiopharmaceutical Solutions Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Radiopharmaceutical Solutions Product Offered
11.1.3 Novartis Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Curium
11.2.1 Curium Company Information
11.2.2 Curium Radiopharmaceutical Solutions Product Offered
11.2.3 Curium Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Curium Main Business Overview
11.2.5 Curium Latest Developments
11.3 Siemens
11.3.1 Siemens Company Information
11.3.2 Siemens Radiopharmaceutical Solutions Product Offered
11.3.3 Siemens Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Siemens Main Business Overview
11.3.5 Siemens Latest Developments
11.4 GE HealthCare
11.4.1 GE HealthCare Company Information
11.4.2 GE HealthCare Radiopharmaceutical Solutions Product Offered
11.4.3 GE HealthCare Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 GE HealthCare Main Business Overview
11.4.5 GE HealthCare Latest Developments
11.5 Lantheus
11.5.1 Lantheus Company Information
11.5.2 Lantheus Radiopharmaceutical Solutions Product Offered
11.5.3 Lantheus Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Lantheus Main Business Overview
11.5.5 Lantheus Latest Developments
11.6 Jubilant Radiopharma
11.6.1 Jubilant Radiopharma Company Information
11.6.2 Jubilant Radiopharma Radiopharmaceutical Solutions Product Offered
11.6.3 Jubilant Radiopharma Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Jubilant Radiopharma Main Business Overview
11.6.5 Jubilant Radiopharma Latest Developments
11.7 Cardinal Health
11.7.1 Cardinal Health Company Information
11.7.2 Cardinal Health Radiopharmaceutical Solutions Product Offered
11.7.3 Cardinal Health Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Cardinal Health Main Business Overview
11.7.5 Cardinal Health Latest Developments
11.8 Telix Pharmaceuticals
11.8.1 Telix Pharmaceuticals Company Information
11.8.2 Telix Pharmaceuticals Radiopharmaceutical Solutions Product Offered
11.8.3 Telix Pharmaceuticals Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Telix Pharmaceuticals Main Business Overview
11.8.5 Telix Pharmaceuticals Latest Developments
11.9 ITM Isotope Technologies Munich
11.9.1 ITM Isotope Technologies Munich Company Information
11.9.2 ITM Isotope Technologies Munich Radiopharmaceutical Solutions Product Offered
11.9.3 ITM Isotope Technologies Munich Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 ITM Isotope Technologies Munich Main Business Overview
11.9.5 ITM Isotope Technologies Munich Latest Developments
11.10 Bracco Imaging
11.10.1 Bracco Imaging Company Information
11.10.2 Bracco Imaging Radiopharmaceutical Solutions Product Offered
11.10.3 Bracco Imaging Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Bracco Imaging Main Business Overview
11.10.5 Bracco Imaging Latest Developments
11.11 Bayer
11.11.1 Bayer Company Information
11.11.2 Bayer Radiopharmaceutical Solutions Product Offered
11.11.3 Bayer Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Bayer Main Business Overview
11.11.5 Bayer Latest Developments
11.12 Eli Lilly
11.12.1 Eli Lilly Company Information
11.12.2 Eli Lilly Radiopharmaceutical Solutions Product Offered
11.12.3 Eli Lilly Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Eli Lilly Main Business Overview
11.12.5 Eli Lilly Latest Developments
11.13 Jubilant Pharma
11.13.1 Jubilant Pharma Company Information
11.13.2 Jubilant Pharma Radiopharmaceutical Solutions Product Offered
11.13.3 Jubilant Pharma Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Jubilant Pharma Main Business Overview
11.13.5 Jubilant Pharma Latest Developments
11.14 Aurobindo Pharma
11.14.1 Aurobindo Pharma Company Information
11.14.2 Aurobindo Pharma Radiopharmaceutical Solutions Product Offered
11.14.3 Aurobindo Pharma Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Aurobindo Pharma Main Business Overview
11.14.5 Aurobindo Pharma Latest Developments
11.15 Sinotau
11.15.1 Sinotau Company Information
11.15.2 Sinotau Radiopharmaceutical Solutions Product Offered
11.15.3 Sinotau Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Sinotau Main Business Overview
11.15.5 Sinotau Latest Developments
11.16 Global Medical Solutions
11.16.1 Global Medical Solutions Company Information
11.16.2 Global Medical Solutions Radiopharmaceutical Solutions Product Offered
11.16.3 Global Medical Solutions Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Global Medical Solutions Main Business Overview
11.16.5 Global Medical Solutions Latest Developments
11.17 SOFIE Biosciences
11.17.1 SOFIE Biosciences Company Information
11.17.2 SOFIE Biosciences Radiopharmaceutical Solutions Product Offered
11.17.3 SOFIE Biosciences Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 SOFIE Biosciences Main Business Overview
11.17.5 SOFIE Biosciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Radiopharmaceutical Solutions Market Size (2021-2032)
2.1.2 Radiopharmaceutical Solutions Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Radiopharmaceutical Solutions by Country/Region (2021, 2025 & 2032)
2.2 Radiopharmaceutical Solutions Segment by Type
2.2.1 Diagnostic Radiopharmaceuticals
2.2.2 Therapeutic Radiopharmaceuticals
2.2.3 Others
2.2.4 Radiopharmaceutical Solutions Market Size by Type
2.2.4.1 Radiopharmaceutical Solutions Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global Radiopharmaceutical Solutions Market Size Market Share by Type (2021-2026)
2.3 Radiopharmaceutical Solutions Segment by Types of Radioactive Nuclides
2.3.1 Radiopharmaceuticals that Emit Single Photons
2.3.2 Radiopharmaceuticals that Emit Positrons
2.3.3 Radiopharmaceuticals that Emit Beta Particles
2.3.4 Radiopharmaceuticals that Emit Alpha Particles
2.3.5 Radiopharmaceutical Solutions Market Size by Types of Radioactive Nuclides
2.3.5.1 Radiopharmaceutical Solutions Market Size CAGR by Types of Radioactive Nuclides (2021 VS 2025 VS 2032)
2.3.5.2 Global Radiopharmaceutical Solutions Market Size Market Share by Types of Radioactive Nuclides (2021-2026)
2.4 Radiopharmaceutical Solutions Segment by Dosage Forms
2.4.1 Injectable Solutions
2.4.2 Oral Solutions
2.4.3 Granules
2.4.4 Others
2.4.5 Radiopharmaceutical Solutions Market Size by Dosage Forms
2.4.5.1 Radiopharmaceutical Solutions Market Size CAGR by Dosage Forms (2021 VS 2025 VS 2032)
2.4.5.2 Global Radiopharmaceutical Solutions Market Size Market Share by Dosage Forms (2021-2026)
2.5 Radiopharmaceutical Solutions Segment by Application
2.5.1 Hospital
2.5.2 Specialist Clinic
2.5.3 Biopharmaceutical Company
2.5.4 Others
2.5.5 Radiopharmaceutical Solutions Market Size by Application
2.5.5.1 Radiopharmaceutical Solutions Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.5.2 Global Radiopharmaceutical Solutions Market Size Market Share by Application (2021-2026)
3 RADIOPHARMACEUTICAL SOLUTIONS MARKET SIZE BY PLAYER
3.1 Radiopharmaceutical Solutions Market Size Market Share by Player
3.1.1 Global Radiopharmaceutical Solutions Revenue by Player (2021-2026)
3.1.2 Global Radiopharmaceutical Solutions Revenue Market Share by Player (2021-2026)
3.2 Global Radiopharmaceutical Solutions Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RADIOPHARMACEUTICAL SOLUTIONS BY REGION
4.1 Radiopharmaceutical Solutions Market Size by Region (2021-2026)
4.2 Global Radiopharmaceutical Solutions Annual Revenue by Country/Region (2021-2026)
4.3 Americas Radiopharmaceutical Solutions Market Size Growth (2021-2026)
4.4 APAC Radiopharmaceutical Solutions Market Size Growth (2021-2026)
4.5 Europe Radiopharmaceutical Solutions Market Size Growth (2021-2026)
4.6 Middle East & Africa Radiopharmaceutical Solutions Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Radiopharmaceutical Solutions Market Size by Country (2021-2026)
5.2 Americas Radiopharmaceutical Solutions Market Size by Type (2021-2026)
5.3 Americas Radiopharmaceutical Solutions Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Radiopharmaceutical Solutions Market Size by Region (2021-2026)
6.2 APAC Radiopharmaceutical Solutions Market Size by Type (2021-2026)
6.3 APAC Radiopharmaceutical Solutions Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Radiopharmaceutical Solutions Market Size by Country (2021-2026)
7.2 Europe Radiopharmaceutical Solutions Market Size by Type (2021-2026)
7.3 Europe Radiopharmaceutical Solutions Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Radiopharmaceutical Solutions by Region (2021-2026)
8.2 Middle East & Africa Radiopharmaceutical Solutions Market Size by Type (2021-2026)
8.3 Middle East & Africa Radiopharmaceutical Solutions Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RADIOPHARMACEUTICAL SOLUTIONS MARKET FORECAST
10.1 Global Radiopharmaceutical Solutions Forecast by Region (2027-2032)
10.1.1 Global Radiopharmaceutical Solutions Forecast by Region (2027-2032)
10.1.2 Americas Radiopharmaceutical Solutions Forecast
10.1.3 APAC Radiopharmaceutical Solutions Forecast
10.1.4 Europe Radiopharmaceutical Solutions Forecast
10.1.5 Middle East & Africa Radiopharmaceutical Solutions Forecast
10.2 Americas Radiopharmaceutical Solutions Forecast by Country (2027-2032)
10.2.1 United States Market Radiopharmaceutical Solutions Forecast
10.2.2 Canada Market Radiopharmaceutical Solutions Forecast
10.2.3 Mexico Market Radiopharmaceutical Solutions Forecast
10.2.4 Brazil Market Radiopharmaceutical Solutions Forecast
10.3 APAC Radiopharmaceutical Solutions Forecast by Region (2027-2032)
10.3.1 China Radiopharmaceutical Solutions Market Forecast
10.3.2 Japan Market Radiopharmaceutical Solutions Forecast
10.3.3 Korea Market Radiopharmaceutical Solutions Forecast
10.3.4 Southeast Asia Market Radiopharmaceutical Solutions Forecast
10.3.5 India Market Radiopharmaceutical Solutions Forecast
10.3.6 Australia Market Radiopharmaceutical Solutions Forecast
10.4 Europe Radiopharmaceutical Solutions Forecast by Country (2027-2032)
10.4.1 Germany Market Radiopharmaceutical Solutions Forecast
10.4.2 France Market Radiopharmaceutical Solutions Forecast
10.4.3 UK Market Radiopharmaceutical Solutions Forecast
10.4.4 Italy Market Radiopharmaceutical Solutions Forecast
10.4.5 Russia Market Radiopharmaceutical Solutions Forecast
10.5 Middle East & Africa Radiopharmaceutical Solutions Forecast by Region (2027-2032)
10.5.1 Egypt Market Radiopharmaceutical Solutions Forecast
10.5.2 South Africa Market Radiopharmaceutical Solutions Forecast
10.5.3 Israel Market Radiopharmaceutical Solutions Forecast
10.5.4 Turkey Market Radiopharmaceutical Solutions Forecast
10.6 Global Radiopharmaceutical Solutions Forecast by Type (2027-2032)
10.7 Global Radiopharmaceutical Solutions Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Radiopharmaceutical Solutions Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Radiopharmaceutical Solutions Product Offered
11.1.3 Novartis Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Curium
11.2.1 Curium Company Information
11.2.2 Curium Radiopharmaceutical Solutions Product Offered
11.2.3 Curium Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Curium Main Business Overview
11.2.5 Curium Latest Developments
11.3 Siemens
11.3.1 Siemens Company Information
11.3.2 Siemens Radiopharmaceutical Solutions Product Offered
11.3.3 Siemens Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Siemens Main Business Overview
11.3.5 Siemens Latest Developments
11.4 GE HealthCare
11.4.1 GE HealthCare Company Information
11.4.2 GE HealthCare Radiopharmaceutical Solutions Product Offered
11.4.3 GE HealthCare Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 GE HealthCare Main Business Overview
11.4.5 GE HealthCare Latest Developments
11.5 Lantheus
11.5.1 Lantheus Company Information
11.5.2 Lantheus Radiopharmaceutical Solutions Product Offered
11.5.3 Lantheus Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Lantheus Main Business Overview
11.5.5 Lantheus Latest Developments
11.6 Jubilant Radiopharma
11.6.1 Jubilant Radiopharma Company Information
11.6.2 Jubilant Radiopharma Radiopharmaceutical Solutions Product Offered
11.6.3 Jubilant Radiopharma Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Jubilant Radiopharma Main Business Overview
11.6.5 Jubilant Radiopharma Latest Developments
11.7 Cardinal Health
11.7.1 Cardinal Health Company Information
11.7.2 Cardinal Health Radiopharmaceutical Solutions Product Offered
11.7.3 Cardinal Health Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Cardinal Health Main Business Overview
11.7.5 Cardinal Health Latest Developments
11.8 Telix Pharmaceuticals
11.8.1 Telix Pharmaceuticals Company Information
11.8.2 Telix Pharmaceuticals Radiopharmaceutical Solutions Product Offered
11.8.3 Telix Pharmaceuticals Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Telix Pharmaceuticals Main Business Overview
11.8.5 Telix Pharmaceuticals Latest Developments
11.9 ITM Isotope Technologies Munich
11.9.1 ITM Isotope Technologies Munich Company Information
11.9.2 ITM Isotope Technologies Munich Radiopharmaceutical Solutions Product Offered
11.9.3 ITM Isotope Technologies Munich Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 ITM Isotope Technologies Munich Main Business Overview
11.9.5 ITM Isotope Technologies Munich Latest Developments
11.10 Bracco Imaging
11.10.1 Bracco Imaging Company Information
11.10.2 Bracco Imaging Radiopharmaceutical Solutions Product Offered
11.10.3 Bracco Imaging Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Bracco Imaging Main Business Overview
11.10.5 Bracco Imaging Latest Developments
11.11 Bayer
11.11.1 Bayer Company Information
11.11.2 Bayer Radiopharmaceutical Solutions Product Offered
11.11.3 Bayer Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Bayer Main Business Overview
11.11.5 Bayer Latest Developments
11.12 Eli Lilly
11.12.1 Eli Lilly Company Information
11.12.2 Eli Lilly Radiopharmaceutical Solutions Product Offered
11.12.3 Eli Lilly Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Eli Lilly Main Business Overview
11.12.5 Eli Lilly Latest Developments
11.13 Jubilant Pharma
11.13.1 Jubilant Pharma Company Information
11.13.2 Jubilant Pharma Radiopharmaceutical Solutions Product Offered
11.13.3 Jubilant Pharma Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Jubilant Pharma Main Business Overview
11.13.5 Jubilant Pharma Latest Developments
11.14 Aurobindo Pharma
11.14.1 Aurobindo Pharma Company Information
11.14.2 Aurobindo Pharma Radiopharmaceutical Solutions Product Offered
11.14.3 Aurobindo Pharma Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Aurobindo Pharma Main Business Overview
11.14.5 Aurobindo Pharma Latest Developments
11.15 Sinotau
11.15.1 Sinotau Company Information
11.15.2 Sinotau Radiopharmaceutical Solutions Product Offered
11.15.3 Sinotau Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Sinotau Main Business Overview
11.15.5 Sinotau Latest Developments
11.16 Global Medical Solutions
11.16.1 Global Medical Solutions Company Information
11.16.2 Global Medical Solutions Radiopharmaceutical Solutions Product Offered
11.16.3 Global Medical Solutions Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Global Medical Solutions Main Business Overview
11.16.5 Global Medical Solutions Latest Developments
11.17 SOFIE Biosciences
11.17.1 SOFIE Biosciences Company Information
11.17.2 SOFIE Biosciences Radiopharmaceutical Solutions Product Offered
11.17.3 SOFIE Biosciences Radiopharmaceutical Solutions Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 SOFIE Biosciences Main Business Overview
11.17.5 SOFIE Biosciences Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Radiopharmaceutical Solutions Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Radiopharmaceutical Solutions Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Diagnostic Radiopharmaceuticals
Table 4. Major Players of Therapeutic Radiopharmaceuticals
Table 5. Major Players of Others
Table 6. Radiopharmaceutical Solutions Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Radiopharmaceutical Solutions Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Radiopharmaceutical Solutions Market Size Market Share by Type (2021-2026)
Table 9. Major Players of Radiopharmaceuticals that Emit Single Photons
Table 10. Major Players of Radiopharmaceuticals that Emit Positrons
Table 11. Major Players of Radiopharmaceuticals that Emit Beta Particles
Table 12. Major Players of Radiopharmaceuticals that Emit Alpha Particles
Table 13. Radiopharmaceutical Solutions Market Size CAGR by Types of Radioactive Nuclides (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Radiopharmaceutical Solutions Market Size by Types of Radioactive Nuclides (2021-2026) & ($ millions)
Table 15. Global Radiopharmaceutical Solutions Market Size Market Share by Types of Radioactive Nuclides (2021-2026)
Table 16. Major Players of Injectable Solutions
Table 17. Major Players of Oral Solutions
Table 18. Major Players of Granules
Table 19. Major Players of Others
Table 20. Radiopharmaceutical Solutions Market Size CAGR by Dosage Forms (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global Radiopharmaceutical Solutions Market Size by Dosage Forms (2021-2026) & ($ millions)
Table 22. Global Radiopharmaceutical Solutions Market Size Market Share by Dosage Forms (2021-2026)
Table 23. Radiopharmaceutical Solutions Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 24. Global Radiopharmaceutical Solutions Market Size by Application (2021-2026) & ($ millions)
Table 25. Global Radiopharmaceutical Solutions Market Size Market Share by Application (2021-2026)
Table 26. Global Radiopharmaceutical Solutions Revenue by Player (2021-2026) & ($ millions)
Table 27. Global Radiopharmaceutical Solutions Revenue Market Share by Player (2021-2026)
Table 28. Radiopharmaceutical Solutions Key Players Head office and Products Offered
Table 29. Radiopharmaceutical Solutions Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 30. New Products and Potential Entrants
Table 31. Mergers & Acquisitions, Expansion
Table 32. Global Radiopharmaceutical Solutions Market Size by Region (2021-2026) & ($ millions)
Table 33. Global Radiopharmaceutical Solutions Market Size Market Share by Region (2021-2026)
Table 34. Global Radiopharmaceutical Solutions Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Radiopharmaceutical Solutions Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Radiopharmaceutical Solutions Market Size by Country (2021-2026) & ($ millions)
Table 37. Americas Radiopharmaceutical Solutions Market Size Market Share by Country (2021-2026)
Table 38. Americas Radiopharmaceutical Solutions Market Size by Type (2021-2026) & ($ millions)
Table 39. Americas Radiopharmaceutical Solutions Market Size Market Share by Type (2021-2026)
Table 40. Americas Radiopharmaceutical Solutions Market Size by Application (2021-2026) & ($ millions)
Table 41. Americas Radiopharmaceutical Solutions Market Size Market Share by Application (2021-2026)
Table 42. APAC Radiopharmaceutical Solutions Market Size by Region (2021-2026) & ($ millions)
Table 43. APAC Radiopharmaceutical Solutions Market Size Market Share by Region (2021-2026)
Table 44. APAC Radiopharmaceutical Solutions Market Size by Type (2021-2026) & ($ millions)
Table 45. APAC Radiopharmaceutical Solutions Market Size by Application (2021-2026) & ($ millions)
Table 46. Europe Radiopharmaceutical Solutions Market Size by Country (2021-2026) & ($ millions)
Table 47. Europe Radiopharmaceutical Solutions Market Size Market Share by Country (2021-2026)
Table 48. Europe Radiopharmaceutical Solutions Market Size by Type (2021-2026) & ($ millions)
Table 49. Europe Radiopharmaceutical Solutions Market Size by Application (2021-2026) & ($ millions)
Table 50. Middle East & Africa Radiopharmaceutical Solutions Market Size by Region (2021-2026) & ($ millions)
Table 51. Middle East & Africa Radiopharmaceutical Solutions Market Size by Type (2021-2026) & ($ millions)
Table 52. Middle East & Africa Radiopharmaceutical Solutions Market Size by Application (2021-2026) & ($ millions)
Table 53. Key Market Drivers & Growth Opportunities of Radiopharmaceutical Solutions
Table 54. Key Market Challenges & Risks of Radiopharmaceutical Solutions
Table 55. Key Industry Trends of Radiopharmaceutical Solutions
Table 56. Global Radiopharmaceutical Solutions Market Size Forecast by Region (2027-2032) & ($ millions)
Table 57. Global Radiopharmaceutical Solutions Market Size Market Share Forecast by Region (2027-2032)
Table 58. Global Radiopharmaceutical Solutions Market Size Forecast by Type (2027-2032) & ($ millions)
Table 59. Global Radiopharmaceutical Solutions Market Size Forecast by Application (2027-2032) & ($ millions)
Table 60. Novartis Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 61. Novartis Radiopharmaceutical Solutions Product Offered
Table 62. Novartis Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Novartis Main Business
Table 64. Novartis Latest Developments
Table 65. Curium Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 66. Curium Radiopharmaceutical Solutions Product Offered
Table 67. Curium Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Curium Main Business
Table 69. Curium Latest Developments
Table 70. Siemens Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 71. Siemens Radiopharmaceutical Solutions Product Offered
Table 72. Siemens Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Siemens Main Business
Table 74. Siemens Latest Developments
Table 75. GE HealthCare Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 76. GE HealthCare Radiopharmaceutical Solutions Product Offered
Table 77. GE HealthCare Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. GE HealthCare Main Business
Table 79. GE HealthCare Latest Developments
Table 80. Lantheus Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 81. Lantheus Radiopharmaceutical Solutions Product Offered
Table 82. Lantheus Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Lantheus Main Business
Table 84. Lantheus Latest Developments
Table 85. Jubilant Radiopharma Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 86. Jubilant Radiopharma Radiopharmaceutical Solutions Product Offered
Table 87. Jubilant Radiopharma Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Jubilant Radiopharma Main Business
Table 89. Jubilant Radiopharma Latest Developments
Table 90. Cardinal Health Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 91. Cardinal Health Radiopharmaceutical Solutions Product Offered
Table 92. Cardinal Health Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Cardinal Health Main Business
Table 94. Cardinal Health Latest Developments
Table 95. Telix Pharmaceuticals Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 96. Telix Pharmaceuticals Radiopharmaceutical Solutions Product Offered
Table 97. Telix Pharmaceuticals Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Telix Pharmaceuticals Main Business
Table 99. Telix Pharmaceuticals Latest Developments
Table 100. ITM Isotope Technologies Munich Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 101. ITM Isotope Technologies Munich Radiopharmaceutical Solutions Product Offered
Table 102. ITM Isotope Technologies Munich Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. ITM Isotope Technologies Munich Main Business
Table 104. ITM Isotope Technologies Munich Latest Developments
Table 105. Bracco Imaging Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 106. Bracco Imaging Radiopharmaceutical Solutions Product Offered
Table 107. Bracco Imaging Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Bracco Imaging Main Business
Table 109. Bracco Imaging Latest Developments
Table 110. Bayer Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 111. Bayer Radiopharmaceutical Solutions Product Offered
Table 112. Bayer Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Bayer Main Business
Table 114. Bayer Latest Developments
Table 115. Eli Lilly Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 116. Eli Lilly Radiopharmaceutical Solutions Product Offered
Table 117. Eli Lilly Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Eli Lilly Main Business
Table 119. Eli Lilly Latest Developments
Table 120. Jubilant Pharma Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 121. Jubilant Pharma Radiopharmaceutical Solutions Product Offered
Table 122. Jubilant Pharma Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Jubilant Pharma Main Business
Table 124. Jubilant Pharma Latest Developments
Table 125. Aurobindo Pharma Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 126. Aurobindo Pharma Radiopharmaceutical Solutions Product Offered
Table 127. Aurobindo Pharma Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Aurobindo Pharma Main Business
Table 129. Aurobindo Pharma Latest Developments
Table 130. Sinotau Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 131. Sinotau Radiopharmaceutical Solutions Product Offered
Table 132. Sinotau Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Sinotau Main Business
Table 134. Sinotau Latest Developments
Table 135. Global Medical Solutions Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 136. Global Medical Solutions Radiopharmaceutical Solutions Product Offered
Table 137. Global Medical Solutions Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Global Medical Solutions Main Business
Table 139. Global Medical Solutions Latest Developments
Table 140. SOFIE Biosciences Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 141. SOFIE Biosciences Radiopharmaceutical Solutions Product Offered
Table 142. SOFIE Biosciences Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. SOFIE Biosciences Main Business
Table 144. SOFIE Biosciences Latest Developments
Table 1. Radiopharmaceutical Solutions Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Radiopharmaceutical Solutions Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Diagnostic Radiopharmaceuticals
Table 4. Major Players of Therapeutic Radiopharmaceuticals
Table 5. Major Players of Others
Table 6. Radiopharmaceutical Solutions Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Radiopharmaceutical Solutions Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Radiopharmaceutical Solutions Market Size Market Share by Type (2021-2026)
Table 9. Major Players of Radiopharmaceuticals that Emit Single Photons
Table 10. Major Players of Radiopharmaceuticals that Emit Positrons
Table 11. Major Players of Radiopharmaceuticals that Emit Beta Particles
Table 12. Major Players of Radiopharmaceuticals that Emit Alpha Particles
Table 13. Radiopharmaceutical Solutions Market Size CAGR by Types of Radioactive Nuclides (2021 VS 2025 VS 2032) & ($ millions)
Table 14. Global Radiopharmaceutical Solutions Market Size by Types of Radioactive Nuclides (2021-2026) & ($ millions)
Table 15. Global Radiopharmaceutical Solutions Market Size Market Share by Types of Radioactive Nuclides (2021-2026)
Table 16. Major Players of Injectable Solutions
Table 17. Major Players of Oral Solutions
Table 18. Major Players of Granules
Table 19. Major Players of Others
Table 20. Radiopharmaceutical Solutions Market Size CAGR by Dosage Forms (2021 VS 2025 VS 2032) & ($ millions)
Table 21. Global Radiopharmaceutical Solutions Market Size by Dosage Forms (2021-2026) & ($ millions)
Table 22. Global Radiopharmaceutical Solutions Market Size Market Share by Dosage Forms (2021-2026)
Table 23. Radiopharmaceutical Solutions Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 24. Global Radiopharmaceutical Solutions Market Size by Application (2021-2026) & ($ millions)
Table 25. Global Radiopharmaceutical Solutions Market Size Market Share by Application (2021-2026)
Table 26. Global Radiopharmaceutical Solutions Revenue by Player (2021-2026) & ($ millions)
Table 27. Global Radiopharmaceutical Solutions Revenue Market Share by Player (2021-2026)
Table 28. Radiopharmaceutical Solutions Key Players Head office and Products Offered
Table 29. Radiopharmaceutical Solutions Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 30. New Products and Potential Entrants
Table 31. Mergers & Acquisitions, Expansion
Table 32. Global Radiopharmaceutical Solutions Market Size by Region (2021-2026) & ($ millions)
Table 33. Global Radiopharmaceutical Solutions Market Size Market Share by Region (2021-2026)
Table 34. Global Radiopharmaceutical Solutions Revenue by Country/Region (2021-2026) & ($ millions)
Table 35. Global Radiopharmaceutical Solutions Revenue Market Share by Country/Region (2021-2026)
Table 36. Americas Radiopharmaceutical Solutions Market Size by Country (2021-2026) & ($ millions)
Table 37. Americas Radiopharmaceutical Solutions Market Size Market Share by Country (2021-2026)
Table 38. Americas Radiopharmaceutical Solutions Market Size by Type (2021-2026) & ($ millions)
Table 39. Americas Radiopharmaceutical Solutions Market Size Market Share by Type (2021-2026)
Table 40. Americas Radiopharmaceutical Solutions Market Size by Application (2021-2026) & ($ millions)
Table 41. Americas Radiopharmaceutical Solutions Market Size Market Share by Application (2021-2026)
Table 42. APAC Radiopharmaceutical Solutions Market Size by Region (2021-2026) & ($ millions)
Table 43. APAC Radiopharmaceutical Solutions Market Size Market Share by Region (2021-2026)
Table 44. APAC Radiopharmaceutical Solutions Market Size by Type (2021-2026) & ($ millions)
Table 45. APAC Radiopharmaceutical Solutions Market Size by Application (2021-2026) & ($ millions)
Table 46. Europe Radiopharmaceutical Solutions Market Size by Country (2021-2026) & ($ millions)
Table 47. Europe Radiopharmaceutical Solutions Market Size Market Share by Country (2021-2026)
Table 48. Europe Radiopharmaceutical Solutions Market Size by Type (2021-2026) & ($ millions)
Table 49. Europe Radiopharmaceutical Solutions Market Size by Application (2021-2026) & ($ millions)
Table 50. Middle East & Africa Radiopharmaceutical Solutions Market Size by Region (2021-2026) & ($ millions)
Table 51. Middle East & Africa Radiopharmaceutical Solutions Market Size by Type (2021-2026) & ($ millions)
Table 52. Middle East & Africa Radiopharmaceutical Solutions Market Size by Application (2021-2026) & ($ millions)
Table 53. Key Market Drivers & Growth Opportunities of Radiopharmaceutical Solutions
Table 54. Key Market Challenges & Risks of Radiopharmaceutical Solutions
Table 55. Key Industry Trends of Radiopharmaceutical Solutions
Table 56. Global Radiopharmaceutical Solutions Market Size Forecast by Region (2027-2032) & ($ millions)
Table 57. Global Radiopharmaceutical Solutions Market Size Market Share Forecast by Region (2027-2032)
Table 58. Global Radiopharmaceutical Solutions Market Size Forecast by Type (2027-2032) & ($ millions)
Table 59. Global Radiopharmaceutical Solutions Market Size Forecast by Application (2027-2032) & ($ millions)
Table 60. Novartis Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 61. Novartis Radiopharmaceutical Solutions Product Offered
Table 62. Novartis Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Novartis Main Business
Table 64. Novartis Latest Developments
Table 65. Curium Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 66. Curium Radiopharmaceutical Solutions Product Offered
Table 67. Curium Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Curium Main Business
Table 69. Curium Latest Developments
Table 70. Siemens Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 71. Siemens Radiopharmaceutical Solutions Product Offered
Table 72. Siemens Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Siemens Main Business
Table 74. Siemens Latest Developments
Table 75. GE HealthCare Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 76. GE HealthCare Radiopharmaceutical Solutions Product Offered
Table 77. GE HealthCare Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. GE HealthCare Main Business
Table 79. GE HealthCare Latest Developments
Table 80. Lantheus Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 81. Lantheus Radiopharmaceutical Solutions Product Offered
Table 82. Lantheus Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Lantheus Main Business
Table 84. Lantheus Latest Developments
Table 85. Jubilant Radiopharma Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 86. Jubilant Radiopharma Radiopharmaceutical Solutions Product Offered
Table 87. Jubilant Radiopharma Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Jubilant Radiopharma Main Business
Table 89. Jubilant Radiopharma Latest Developments
Table 90. Cardinal Health Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 91. Cardinal Health Radiopharmaceutical Solutions Product Offered
Table 92. Cardinal Health Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Cardinal Health Main Business
Table 94. Cardinal Health Latest Developments
Table 95. Telix Pharmaceuticals Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 96. Telix Pharmaceuticals Radiopharmaceutical Solutions Product Offered
Table 97. Telix Pharmaceuticals Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. Telix Pharmaceuticals Main Business
Table 99. Telix Pharmaceuticals Latest Developments
Table 100. ITM Isotope Technologies Munich Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 101. ITM Isotope Technologies Munich Radiopharmaceutical Solutions Product Offered
Table 102. ITM Isotope Technologies Munich Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. ITM Isotope Technologies Munich Main Business
Table 104. ITM Isotope Technologies Munich Latest Developments
Table 105. Bracco Imaging Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 106. Bracco Imaging Radiopharmaceutical Solutions Product Offered
Table 107. Bracco Imaging Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Bracco Imaging Main Business
Table 109. Bracco Imaging Latest Developments
Table 110. Bayer Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 111. Bayer Radiopharmaceutical Solutions Product Offered
Table 112. Bayer Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Bayer Main Business
Table 114. Bayer Latest Developments
Table 115. Eli Lilly Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 116. Eli Lilly Radiopharmaceutical Solutions Product Offered
Table 117. Eli Lilly Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Eli Lilly Main Business
Table 119. Eli Lilly Latest Developments
Table 120. Jubilant Pharma Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 121. Jubilant Pharma Radiopharmaceutical Solutions Product Offered
Table 122. Jubilant Pharma Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Jubilant Pharma Main Business
Table 124. Jubilant Pharma Latest Developments
Table 125. Aurobindo Pharma Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 126. Aurobindo Pharma Radiopharmaceutical Solutions Product Offered
Table 127. Aurobindo Pharma Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. Aurobindo Pharma Main Business
Table 129. Aurobindo Pharma Latest Developments
Table 130. Sinotau Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 131. Sinotau Radiopharmaceutical Solutions Product Offered
Table 132. Sinotau Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Sinotau Main Business
Table 134. Sinotau Latest Developments
Table 135. Global Medical Solutions Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 136. Global Medical Solutions Radiopharmaceutical Solutions Product Offered
Table 137. Global Medical Solutions Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Global Medical Solutions Main Business
Table 139. Global Medical Solutions Latest Developments
Table 140. SOFIE Biosciences Details, Company Type, Radiopharmaceutical Solutions Area Served and Its Competitors
Table 141. SOFIE Biosciences Radiopharmaceutical Solutions Product Offered
Table 142. SOFIE Biosciences Radiopharmaceutical Solutions Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. SOFIE Biosciences Main Business
Table 144. SOFIE Biosciences Latest Developments
LIST OF FIGURES
Figure 1. Radiopharmaceutical Solutions Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Radiopharmaceutical Solutions Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Radiopharmaceutical Solutions Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Radiopharmaceutical Solutions Sales Market Share by Country/Region (2025)
Figure 8. Radiopharmaceutical Solutions Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Radiopharmaceutical Solutions Market Size Market Share by Type in 2025
Figure 10. Global Radiopharmaceutical Solutions Market Size Market Share by Types of Radioactive Nuclides in 2025
Figure 11. Global Radiopharmaceutical Solutions Market Size Market Share by Dosage Forms in 2025
Figure 12. Radiopharmaceutical Solutions in Hospital
Figure 13. Global Radiopharmaceutical Solutions Market: Hospital (2021-2026) & ($ millions)
Figure 14. Radiopharmaceutical Solutions in Specialist Clinic
Figure 15. Global Radiopharmaceutical Solutions Market: Specialist Clinic (2021-2026) & ($ millions)
Figure 16. Radiopharmaceutical Solutions in Biopharmaceutical Company
Figure 17. Global Radiopharmaceutical Solutions Market: Biopharmaceutical Company (2021-2026) & ($ millions)
Figure 18. Radiopharmaceutical Solutions in Others
Figure 19. Global Radiopharmaceutical Solutions Market: Others (2021-2026) & ($ millions)
Figure 20. Global Radiopharmaceutical Solutions Market Size Market Share by Application in 2025
Figure 21. Global Radiopharmaceutical Solutions Revenue Market Share by Player in 2025
Figure 22. Global Radiopharmaceutical Solutions Market Size Market Share by Region (2021-2026)
Figure 23. Americas Radiopharmaceutical Solutions Market Size 2021-2026 ($ millions)
Figure 24. APAC Radiopharmaceutical Solutions Market Size 2021-2026 ($ millions)
Figure 25. Europe Radiopharmaceutical Solutions Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Radiopharmaceutical Solutions Market Size 2021-2026 ($ millions)
Figure 27. Americas Radiopharmaceutical Solutions Value Market Share by Country in 2025
Figure 28. United States Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Radiopharmaceutical Solutions Market Size Market Share by Region in 2025
Figure 33. APAC Radiopharmaceutical Solutions Market Size Market Share by Type (2021-2026)
Figure 34. APAC Radiopharmaceutical Solutions Market Size Market Share by Application (2021-2026)
Figure 35. China Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 39. India Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Radiopharmaceutical Solutions Market Size Market Share by Country in 2025
Figure 42. Europe Radiopharmaceutical Solutions Market Size Market Share by Type (2021-2026)
Figure 43. Europe Radiopharmaceutical Solutions Market Size Market Share by Application (2021-2026)
Figure 44. Germany Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 45. France Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Radiopharmaceutical Solutions Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Radiopharmaceutical Solutions Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Radiopharmaceutical Solutions Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 58. APAC Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 59. Europe Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 61. United States Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 62. Canada Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 63. Mexico Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 64. Brazil Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 65. China Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 66. Japan Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 67. Korea Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 69. India Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 70. Australia Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 71. Germany Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 72. France Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 73. UK Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 74. Italy Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 75. Russia Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 76. Egypt Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 77. South Africa Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 78. Israel Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 79. Turkey Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 80. Global Radiopharmaceutical Solutions Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Radiopharmaceutical Solutions Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 1. Radiopharmaceutical Solutions Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Radiopharmaceutical Solutions Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Radiopharmaceutical Solutions Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Radiopharmaceutical Solutions Sales Market Share by Country/Region (2025)
Figure 8. Radiopharmaceutical Solutions Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Radiopharmaceutical Solutions Market Size Market Share by Type in 2025
Figure 10. Global Radiopharmaceutical Solutions Market Size Market Share by Types of Radioactive Nuclides in 2025
Figure 11. Global Radiopharmaceutical Solutions Market Size Market Share by Dosage Forms in 2025
Figure 12. Radiopharmaceutical Solutions in Hospital
Figure 13. Global Radiopharmaceutical Solutions Market: Hospital (2021-2026) & ($ millions)
Figure 14. Radiopharmaceutical Solutions in Specialist Clinic
Figure 15. Global Radiopharmaceutical Solutions Market: Specialist Clinic (2021-2026) & ($ millions)
Figure 16. Radiopharmaceutical Solutions in Biopharmaceutical Company
Figure 17. Global Radiopharmaceutical Solutions Market: Biopharmaceutical Company (2021-2026) & ($ millions)
Figure 18. Radiopharmaceutical Solutions in Others
Figure 19. Global Radiopharmaceutical Solutions Market: Others (2021-2026) & ($ millions)
Figure 20. Global Radiopharmaceutical Solutions Market Size Market Share by Application in 2025
Figure 21. Global Radiopharmaceutical Solutions Revenue Market Share by Player in 2025
Figure 22. Global Radiopharmaceutical Solutions Market Size Market Share by Region (2021-2026)
Figure 23. Americas Radiopharmaceutical Solutions Market Size 2021-2026 ($ millions)
Figure 24. APAC Radiopharmaceutical Solutions Market Size 2021-2026 ($ millions)
Figure 25. Europe Radiopharmaceutical Solutions Market Size 2021-2026 ($ millions)
Figure 26. Middle East & Africa Radiopharmaceutical Solutions Market Size 2021-2026 ($ millions)
Figure 27. Americas Radiopharmaceutical Solutions Value Market Share by Country in 2025
Figure 28. United States Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 29. Canada Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 30. Mexico Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 31. Brazil Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 32. APAC Radiopharmaceutical Solutions Market Size Market Share by Region in 2025
Figure 33. APAC Radiopharmaceutical Solutions Market Size Market Share by Type (2021-2026)
Figure 34. APAC Radiopharmaceutical Solutions Market Size Market Share by Application (2021-2026)
Figure 35. China Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 36. Japan Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 37. South Korea Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 38. Southeast Asia Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 39. India Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 40. Australia Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 41. Europe Radiopharmaceutical Solutions Market Size Market Share by Country in 2025
Figure 42. Europe Radiopharmaceutical Solutions Market Size Market Share by Type (2021-2026)
Figure 43. Europe Radiopharmaceutical Solutions Market Size Market Share by Application (2021-2026)
Figure 44. Germany Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 45. France Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 46. UK Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 47. Italy Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 48. Russia Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 49. Middle East & Africa Radiopharmaceutical Solutions Market Size Market Share by Region (2021-2026)
Figure 50. Middle East & Africa Radiopharmaceutical Solutions Market Size Market Share by Type (2021-2026)
Figure 51. Middle East & Africa Radiopharmaceutical Solutions Market Size Market Share by Application (2021-2026)
Figure 52. Egypt Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 53. South Africa Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 54. Israel Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 55. Turkey Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 56. GCC Countries Radiopharmaceutical Solutions Market Size Growth 2021-2026 ($ millions)
Figure 57. Americas Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 58. APAC Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 59. Europe Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 60. Middle East & Africa Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 61. United States Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 62. Canada Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 63. Mexico Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 64. Brazil Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 65. China Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 66. Japan Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 67. Korea Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 68. Southeast Asia Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 69. India Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 70. Australia Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 71. Germany Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 72. France Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 73. UK Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 74. Italy Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 75. Russia Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 76. Egypt Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 77. South Africa Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 78. Israel Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 79. Turkey Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
Figure 80. Global Radiopharmaceutical Solutions Market Size Market Share Forecast by Type (2027-2032)
Figure 81. Global Radiopharmaceutical Solutions Market Size Market Share Forecast by Application (2027-2032)
Figure 82. GCC Countries Radiopharmaceutical Solutions Market Size 2027-2032 ($ millions)
